Scarica l'app Stockscreener
1.60
5.96%
0.09
Dopo l'orario di chiusura:
1.59
-0.01
-0.63%
Precedente Chiudi:
$1.51
Aprire:
$1.51
Volume 24 ore:
46,882
Relative Volume:
0.08
Capitalizzazione di mercato:
$6.09M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-0.7477
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
-5.33%
1M Prestazione:
+17.65%
6M Prestazione:
-48.61%
1 anno Prestazione:
-53.35%
Intervallo 1D:
$1.4701
$1.6302
Intervallo di 1 settimana:
$1.43
$1.77
Portata 52W:
$1.28
$6.25
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.60 | 5.75M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Cyclerion Therapeutics Inc. stock sustain institutional interestTrade Performance Summary & Safe Swing Trade Setups - Newser
Does Cyclerion Therapeutics Inc. stock trade at a discount to peersWeekly Loss Report & Verified Momentum Watchlists - Newser
How currency fluctuations impact Cyclerion Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Cyclerion Therapeutics (CYCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cyclerion Therapeutics Inc. stock attractive for growth ETFsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Cyclerion Receives Milestone Payment from Akebia - TipRanks
Cyclerion Therapeutics Announces Milestone Payment from Akebia - TradingView — Track All Markets
Akebia Therapeutics, Inc. Initiates Phase 2 Clinical Trials for the Treatment of Focused Segmental Glomerulosclerosis Using Praliciguat - marketscreener.com
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & High Return Wealth Plans - earlytimes.in
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings seasonWeekly Stock Report & Short-Term Trading Opportunity Alerts - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Cyclerion Therapeutics, Inc. Quarterly Earnings Report | CYCN SEC FilingForm 10-Q - Stock Titan
Short interest data insights for Cyclerion Therapeutics Inc.Weekly Trend Report & Fast Moving Market Watchlists - newser.com
Prepare Yourself for Liftoff: Cyclerion Therapeutics Inc (CYCN) - Setenews
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics - Yahoo Finance
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network - Benzinga
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsForecast Cut & Daily Technical Forecast Reports - newser.com
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):